CD44 and neoplasm: Moreover, CQ increased the sensitivity to PTX and reduced lung metastases, tumor growth, and recurrence in orthotopic murine MDAMB231 and SUM159PT tumor models and diminished the CD44+/CD24−/low CSC population in a clinical trial [32].